Richmond Pharmacology is excited to attend the 2024 American HeartAssociation (AHA) Scientific Sessions in Philadelphia. This premier event incardiovascular science will bring together global leaders to present anddiscuss the latest innovations in cardiovascular research, prevention, andtreatment. The sessions will cover a wide range of topics, including basic,clinical, and population science.

To connect with our team during the event, please reach out to arrange ameeting.

For more information, visit the AHA Scientific Sessions 2024 website.

Latest news

Richmond CEO Presents Landmark Data on Repeat-Dose Gene Editing

September 9, 2024
Richmond CEO Presents Landmark Data on Repeat-Dose Gene Editing
Read more

Richmond promotes new Director of Communications and Participant Engagement

August 12, 2024
Richmond Pharmacology is delighted to announce the promotion of Liz Romano to the new position of Director of Communications and Participant Engagement.
Read more

Events

Pulse Virtual: Respiratory, CVD, Diabetes and Nutrition

Wednesday 18th September
Richmond will be presenting at the upcoming Pulse Virtual Event aimed at GPs
View event